Picotamide is a small molecule drug with a maximum clinical trial phase of IV and is indicated in recurrent thrombophlebitis. It is grouped under the following drug class(es): Antiplatelets. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include 4-Methoxy-N, N’-bis(3-pyridinylmethyl)-1, 3-benzenedicarboxamide, N and N’-Bis(3-picolyl)-4-methoxyisophthalamide. Its PubChem CID is 4814.
Picotamide
| CAS No | 32828-81-2 |
|---|---|
| Molecular Formula | C21H20N4O3 |
| Molecular Weight | 376.4 g/mol |
| Synonyms | 4-methoxy-1-N,3-N-bis(pyridin-3-ylmethyl)benzene-1,3-dicarboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Picotamide is a small molecule drug with a maximum clinical trial phase of IV and is indicated in recurrent thrombophlebitis. It is grouped under the following drug class(es): Antiplatelets.
The listed CAS number is 32828-81-2.
The listed molecular formula is C21H20N4O3.
The listed molecular weight is 376.4 g/mol.
4-methoxy-1-N,3-N-bis(pyridin-3-ylmethyl)benzene-1,3-dicarboxamide.
The source lists 4-Methoxy-N, N'-bis(3-pyridinylmethyl)-1, 3-benzenedicarboxamide, N and N'-Bis(3-picolyl)-4-methoxyisophthalamide.